Jonathan Payne, MD
Orthopaedic Surgery · Athens, GANPI 1649512039
Payments from drug & device makers
Across 44 payments — averaging $76.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Orthopedics LLC$1K
- Zimmer Biomet$669
- Stryker$512
- Smith+Nephew$329
- Bioventus LLC$141
- Anika Therapeutics, Inc.$68
- plus $309 from 12 others
What the payments were for
- Consulting fees$471%
- Travel & lodging$1,71351%
- Food & beverage$1,61648%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Orthopedics LLC | 4 | $1,347 |
| Zimmer Biomet | 5 | $669 |
| Stryker | 8 | $512 |
| Smith+Nephew | 5 | $329 |
| Bioventus LLC | 6 | $141 |
| Anika Therapeutics, Inc. | 2 | $68 |
| Orthalign Inc | 1 | $54 |
| Vericel Corporation | 2 | $39 |
| Boston Scientific | 1 | $39 |
| Arthrex | 2 | $38 |
| GE HealthCare | 1 | $27 |
| Acera Surgical, Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $22 |
| Innovation Technologies Inc | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Amgen | 1 | $15 |
| Hydrofera LLC | 1 | $13 |
| Ossio Inc | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,375 in reported general payments places this provider in the 45th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 48 | $629 |
| Naproxen | 72 | $512 |
| Ondansetron Hcl | 69 | $405 |
| Meloxicam | 130 | $238 |
| Gabapentin | 25 | $234 |
| Oxycodone Hcl | 61 | $222 |
| Cefadroxil | 22 | $180 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $174 |
| Methylprednisolone | 20 | $135 |
| Tramadol Hcl | 41 | $87 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $72 |
| Tizanidine Hcl | 17 | $67 |
| Amoxicillin | 28 | $48 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Athens
- Ormonde MahoneyAthens$10.8M
- William TallyAthens$870K
- Julian PriceAthens$805K
- Charles OgburnAthens$248K
- John DorrisAthens$68K
- Charles DecookCumming$48.3M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.